Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash $ 24,782,128 $ 33,785
Accounts receivable, net 1,373,754 38,704
Prepaid expenses and other current assets 107,651 28,072
Total Current Assets 26,263,533 100,561
Intangible assets, net 1,071,850 83,333
Property and equipment, net 17,166 4,549
Deferred offering costs 10,000 285,196
Total Assets 27,362,549 473,639
Current Liabilities:    
Accounts payable - suppliers 336,028 785,180
Accounts payable - trade 1,106,604 867,554
Accrued expenses and other current liabilities 1,028,307 478,674
Accrued interest 3,975 117,912
Accrued interest - related parties 0 4,204
Due to related party   29,000
Notes payable, current portion 218,461 113,967
Convertible notes payable, current portion, net of discount of $0 and $630,994 as of December 31, 2020 and 2019, respectively   2,569,006
Convertible notes payable - related parties, current portion, net of discount of $0 and $281,701 as of December 31, 2020 and 2019, respectively   548,799
Total Current Liabilities 2,693,375 5,514,296
Notes payable, non-current portion 187,629  
Total Liabilities 2,881,004 5,514,296
Commitments and contingencies (Note 9)
Stockholders' Equity (Deficiency):    
Common stock, $0.00001 par value; 95,000,000 shares authorized; 11,756,109 and 3,601,521 shares issued and outstanding as of December 31, 2020 and 2019, respectively 118 36
Additional paid-in capital 40,770,504 3,362,724
Accumulated deficit (16,289,077) (8,403,417)
Total Stockholders' Equity (Deficiency) 24,481,545 (5,040,657)
Total Liabilities and Stockholders' Equity (Deficiency) $ 27,362,549 $ 473,639